The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges
Crossref DOI link: https://doi.org/10.1007/s10198-017-0933-3
Published Online: 2017-10-14
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ghabri, Salah
Mauskopf, Josephine
License valid from 2017-10-14